US · ai · biotech · drug discovery
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Dec 2025 · $130M
General Catalyst lead, Oak HC/FT lead, Thrive Capital, Menlo Ventures, SV Angel, Neo, Lachy Groom, Emerson Collective, OpenAI, Glade Brook, Dimension, Yosemite venture fund
Reported by TechCrunch
Missing a round, or an investor who was in one? Tell us.